Brainstorm Cell Therapeutics (BCLI) Expected to Announce Quarterly Earnings on Monday

Brainstorm Cell Therapeutics (NASDAQ: BCLI - Get Free Report) is anticipated to release its Q4 2025 results before the market opens on Monday, March 30th. Analysts expect Brainstorm Cell Therapeutics to post earnings of ($0.28) per share for the quarter. Interested persons can find conference call details on the company's upcoming Q4 2025 earning report page